Company / Cost of Revenue
DNA X, Inc. Cost of Revenue History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$74.3M
FY2024
5-year range
$48.2M / $81.7M
FY2020-FY2024
Trend
+27.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $48M to $74M over the past 2 years.
Based on SEC 10-K filings.
$74M in FY2024 with a 5-year CAGR of -3.2%.
Increased from $48M to $74M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +15.1%
- 5-Year CAGR
- -3.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -3.2%, indicating a declining trend.
- In FY2024, cost of revenue increased 27.7% year-over-year.
- Peak cost of revenue was recorded in FY2019.
- Lowest cost of revenue in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $74.3M | +27.7% |
| FY2023 | $58.2M | +20.9% |
| FY2022 | $48.2M | -1.3% |
| FY2021 | $48.8M | -40.3% |
| FY2020 | $81.7M | -6.7% |
| FY2019 | $87.6M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026